Literature DB >> 30928422

Etiology, presenting features and outcome of children with non-cirrhotic portal vein thrombosis: A multicentre national study.

Angelo Di Giorgio1, Paola De Angelis2, Maurizio Cheli3, Pietro Vajro4, Raffaele Iorio5, Mara Cananzi6, Silvia Riva7, Giuseppe Maggiore8, Giuseppe Indolfi9, Pier Luigi Calvo10, Emanuele Nicastro1, Lorenzo D'Antiga11.   

Abstract

OBJECTIVES: Non-cirrhotic portal vein thrombosis (PVT) is a main cause of portal hypertension in children. We describe the characteristics at presentation and outcome of a cohort of patients with PVT to determine clinical features and predictors of outcome.
METHODS: We recorded: (1) Associated factors: prematurity, congenital malformations, neonatal illnesses, umbilical vein catheterization (UVC), deep infections, surgery; (2) congenital and acquired prothrombotic disorders; (3) features at last follow up including survival rate and need for surgery.
RESULTS: 187 patients, mean age at diagnosis 4 ± 3.7 years, had a history of prematurity (61%); UVC (65%); neonatal illnesses (79%). The diagnosis followed the detection of splenomegaly (40%), gastrointestinal bleeding (36%), hypersplenism (6%), or was incidental (18%). Of 71 patients who had endoscopy at presentation 62 (87%) had oesophageal varices. After 11.3 years' follow up 63 (34%) required surgery or TIPS. Ten-year survival rate was 98%, with 90% shunt patency. Spleen size, variceal bleeding and hypersplenism at presentation were predictors of surgery or TIPS (p < 0.05).
CONCLUSION: PVT is associated with congenital and acquired co-morbidities. History of prematurity, neonatal illnesses and UVC should lead to rule out PVT. Large spleen, variceal bleeding and hypersplenism at presentation predict the need for eventual surgery in a third of cases.
Copyright © 2019 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Children; Extra-hepatic portal vein obstruction; Non-cirrhotic portal hypertension; Portal vein thrombosis

Year:  2019        PMID: 30928422     DOI: 10.1016/j.dld.2019.02.014

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  8 in total

1.  Band ligation versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis.

Authors:  Lorena I Cifuentes; Daniela Gattini; Romina Torres-Robles; Juan Cristóbal Gana
Journal:  Cochrane Database Syst Rev       Date:  2021-01-26

2.  Beta-blockers versus placebo or no intervention for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis.

Authors:  Lorena I Cifuentes; Daniela Gattini; Romina Torres-Robles; Juan Cristóbal Gana
Journal:  Cochrane Database Syst Rev       Date:  2021-01-26

Review 3.  Venous thrombosis in neonates.

Authors:  Mihir D Bhatt; Anthony Kc Chan
Journal:  Fac Rev       Date:  2021-02-25

4.  Sclerotherapy versus beta-blockers for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis.

Authors:  Daniela Gattini; Lorena I Cifuentes; Romina Torres-Robles; Juan Cristóbal Gana
Journal:  Cochrane Database Syst Rev       Date:  2020-01-10

5.  Band ligation versus sclerotherapy for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis.

Authors:  Juan Cristóbal Gana; Lorena I Cifuentes; Daniela Gattini; Romina Torres-Robles
Journal:  Cochrane Database Syst Rev       Date:  2020-11-06

6.  Sclerotherapy versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis.

Authors:  Daniela Gattini; Lorena I Cifuentes; Romina Torres-Robles; Juan Cristóbal Gana
Journal:  Cochrane Database Syst Rev       Date:  2020-03-05

7.  Incidence of umbilical vein catheter-associated thrombosis of the portal system: A systematic review and meta-analysis.

Authors:  Iliana Bersani; Fiammetta Piersigilli; Giulia Iacona; Immacolata Savarese; Francesca Campi; Andrea Dotta; Cinzia Auriti; Enrico Di Stasio; Matteo Garcovich
Journal:  World J Hepatol       Date:  2021-11-27

8.  Natural Course of Pediatric Portal Hypertension.

Authors:  Al-Faraaz Kassam; Gillian R Goddard; Michael E Johnston; Alexander R Cortez; Andrew T Trout; Todd M Jenkins; Alexander G Miethke; Kathleen M Campbell; Jorge A Bezerra; William F Balistreri; Jaimie D Nathan; Maria H Alonso; Gregory M Tiao; Alexander J Bondoc
Journal:  Hepatol Commun       Date:  2020-07-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.